Phase 3 trial reports one dose of Ad5-nCoV COVID-19 vaccine is safe and effective, including against severe disease
Today UK News,
Credit: Pixabay/CC0 Public Domain One dose of Ad5-nCoV (Convidecia), a COVID-19 vaccine developed in China, is 57.5% effective…